Goldman Sachs Starts Precision BioSciences Inc. (DTIL) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to Goldman Sachs Starts Precision BioSciences Inc. (DTIL) at Buy
April 22, 2019 6:42 AM EDT
Jefferies analyst Maury Raycroft initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Buy rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Precision BioSciences Inc.... More
April 22, 2019 1:41 AM EDT
JPMorgan analyst Eric Joseph initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Overweight rating and a price target of $23.00.
Favors the company's competitive positioning in the manufacture of off-the0-shelf CAR Ts which is likely the next...
More
April 22, 2019 12:45 AM EDT
Barclays analyst Gena Wang initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Overweight rating and a price target of $24.00.
Believes the company's proprietary ARCUS genome-editing platform possesses unique advantages with editing efficiency largely comparable to other gene editing...
More
